Express Scripts (ESRX): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Express Scripts (ESRX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.1%. By the end of trading, Express Scripts rose 89 cents (1.4%) to $62.62 on average volume. Throughout the day, 3.8 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.8 million shares. The stock ranged in a price between $61.71-$62.80 after having opened the day at $61.97 as compared to the previous trading day's close of $61.73. Other companies within the Health Services industry that increased today were: TearLab Corpoartion (TEAR), up 9.2%, Iridex Corporation (IRIX), up 7.1%, LCA-Vision (LCAV), up 6.7%, and CAS Medical Systems (CASM), up 5.3%.

• ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services in North America. Express Scripts has a market cap of $50.13 billion and is part of the health care sector. The company has a P/E ratio of 32.2, above the average health services industry P/E ratio of 30.6 and above the S&P 500 P/E ratio of 17.7. Shares are up 38.4% year to date as of the close of trading on Thursday. Currently there are 18 analysts that rate Express Scripts a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

• You can view the full Express Scripts Ratings Report.

• Use our health services section to find industry-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR (XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care (RXD).

• Find other investment ideas from our top rated ETFs lists.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.

For more information on Express Scripts click any of the following:

• Express Scripts Stock Price

• Express Scripts Analyst Ratings

• Express Scripts Key Stats & Profile

• Express Scripts Earnings

• Express Scripts Ratio Comparison

• Express Scripts Growth Rates

• Express Scripts Balance Sheet

• Express Scripts Cash Flow

• Express Scripts Income Statement